CINECA IRIS Institutional Research Information System

LUNGHI, CARLOTTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.235
SA - Sud America 526
NA - Nord America 185
EU - Europa 150
AF - Africa 20
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.120
Salva come PNG Salva come JPEG
Nazione #
BR - Brasile 403
HK - Hong Kong 328
SG - Singapore 272
VN - Vietnam 271
US - Stati Uniti d'America 152
KR - Corea 145
CN - Cina 137
AR - Argentina 55
IT - Italia 35
EC - Ecuador 30
ID - Indonesia 30
DE - Germania 29
FR - Francia 28
MX - Messico 18
CO - Colombia 13
PY - Paraguay 11
RU - Federazione Russa 10
GB - Regno Unito 9
NL - Olanda 9
CA - Canada 8
IN - India 7
PK - Pakistan 7
UA - Ucraina 7
ZA - Sudafrica 7
BD - Bangladesh 6
IQ - Iraq 6
FI - Finlandia 5
MA - Marocco 5
AZ - Azerbaigian 4
CL - Cile 4
TR - Turchia 4
VE - Venezuela 4
EE - Estonia 3
KW - Kuwait 3
KZ - Kazakistan 3
PE - Perù 3
PL - Polonia 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
BG - Bulgaria 2
HN - Honduras 2
JO - Giordania 2
MK - Macedonia 2
PR - Porto Rico 2
PT - Portogallo 2
SA - Arabia Saudita 2
TN - Tunisia 2
CG - Congo 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
ES - Italia 1
ET - Etiopia 1
GT - Guatemala 1
IL - Israele 1
JM - Giamaica 1
JP - Giappone 1
KE - Kenya 1
LK - Sri Lanka 1
LV - Lettonia 1
NC - Nuova Caledonia 1
NE - Niger 1
NO - Norvegia 1
OM - Oman 1
RE - Reunion 1
RO - Romania 1
SI - Slovenia 1
TH - Thailandia 1
UZ - Uzbekistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 2.120
Salva come PNG Salva come JPEG
Città #
Hong Kong 326
Seoul 145
Ho Chi Minh City 107
Singapore 95
Dallas 48
Hanoi 39
São Paulo 36
Beijing 24
Rio de Janeiro 20
Da Nang 16
Biên Hòa 14
Ashburn 13
Sona 12
Campinas 11
Haiphong 11
Mexico City 11
Quito 11
Guayaquil 10
Curitiba 9
Thái Bình 9
Düsseldorf 8
Manaus 8
Munich 8
New York 8
Ninh Bình 8
Brasília 7
Florence 6
Hải Dương 6
Los Angeles 6
Montreal 6
Amsterdam 5
Bắc Ninh 5
Can Tho 5
Frankfurt am Main 5
Goiânia 5
Porto Alegre 5
Baku 4
Buenos Aires 4
Hortolândia 4
Lauterbourg 4
Milan 4
Osasco 4
Roubaix 4
Santa Clara 4
Thái Nguyên 4
Turku 4
Asunción 3
Chicago 3
Denver 3
Formosa 3
Franca 3
Ha Long 3
Hillsboro 3
Lanús 3
London 3
Piracicaba 3
Portsmouth 3
Santo André 3
São Bernardo do Campo 3
São José do Rio Preto 3
Taubaté 3
Almaty 2
Amman 2
Ankara 2
As Sālimīyah 2
Baghdad 2
Belo Horizonte 2
Birigui 2
Bogotá 2
Boksburg 2
Bountiful 2
Brooklyn 2
Bucaramanga 2
Buffalo 2
Bình Dương 2
Cachoeiro de Itapemirim 2
Cajazeiras 2
Campo Grande 2
Canoas 2
Cao Lanh 2
Caxias do Sul 2
Ciudad del Este 2
Concepción 2
Council Bluffs 2
Cuenca 2
El Guabo 2
Extrema 2
Faisalabad 2
Feira de Santana 2
Formiga 2
Francisco Santos 2
Guarulhos 2
Imperatriz 2
Indaiatuba 2
Itapema 2
Itaquaquecetuba 2
Jakarta 2
Juatuba 2
Juiz de Fora 2
Karachi 2
Totale 1.231
Salva come PNG Salva come JPEG
Nome #
Dosing of Cannabinoids Associated with an Opioid-Sparing Effect: A Systematic Review of Longitudinal Studies 46
Changes in self-rated physical and mental health and life satisfaction associated with opioid and potentially inappropriate opioid prescribing in primary care older adults 44
Deprescribing as a strategy for improving safety of medicines in older people: Clinical and regulatory perspective 42
Drug Prescription Monitoring System To Estimate Incidence and Prevalence of Type 1 Diabetes 41
Alternative mechanistic paths in the Hetero-Diels-Alder reaction of α-oxothiones: A theoretical study 41
Treatment sequences in moderate-to-severe psoriasis: a hospital-based retrospective analysis 41
SYNHETIC IMMUNOGENIC GLYCOCONJUGATE FOR MELANOMA IMMUNOTHERAPY 37
Association Between Depression And Discontinuation With Antidiabetic Drugs 37
From adoption to impact: linking prescribing tools to clinical outcomes—authors’ response 37
Definition and validation of case detection algorithms using Quebec medico-administrative databases (med-echo and ramq) for depression among seniors 36
Trends in benzodiazepine and alternative hypnotic use in relation with multimorbidity among older adults in Quebec, Canada 36
Depression but not non-persistence to antidiabetic drugs is associated with mortality in type 2 diabetes: A nested case-control study 36
Benefits, risks and impacts on quality of life of medications used in multimorbid older adults: a Delphi study 36
Exposure to guideline-recommended drugs after a first acute myocardial infarction in older adults: does deprivation matter? 36
The delicate choice of optimal basic therapy for multimorbid older adults: A cross-sectional survey 35
The Association Between Depression and Medication Non-Adherence in Type 2 Diabetes: A Population-Based Cohort Study 34
Multimorbidity Treatment Burden Questionnaire (MTBQ): Translation, Cultural Adaptation, and Validation in French-Canadian 34
Synthesis, conformational studies, binding assessment and liposome insertion of a thioether-bridged mimetic of the antigen GM3 ganglioside lactone 33
Early career researchers’ perspectives and roles in patient-oriented research 33
Prevalence of Depression in Patients with Type 2 Diabetes in Quebec: A Population-Based Cohort Study 32
Depression but not non-persistence to antidiabetic drugs is associated with mortality in type 2 diabetes 30
Economic evaluations of interventions to optimize medication use in older adults with polypharmacy and multimorbidity: A systematic review 30
Comorbidity, trauma, and mortality in children and young adults using ADHD medications in Quebec between 2000 and 2020 30
ADHD medications use and risk of mortality and unintentional injuries: a population-based cohort study 30
Is it time to consider depression as a major complication of type 2 diabetes? Evidence from a large population-based cohort study 30
Depression and the risk of hospitalization in type 2 diabetes patients: A nested case-control study accounting for non-persistence to antidiabetic treatment 29
The interface of depression and diabetes: treatment considerations 29
Trajectories of Antidiabetic Medication Adherence in Older Adults and the Effect of Depression and Anxiety Symptoms 28
Morbidities and mortality of diagnosed attention deficit hyperactivity disorder (ADHD) over the youth lifespan: A population-based retrospective cohort study 28
LONG-TERM UTILIZATION OF ANTIDEPRESSANT DRUGS: PREVALENCE AND ASSOCIATED FACTORS 28
Medical cannabis authorization and risk of emergency department visits and hospitalization due to psychotic disorders: A propensity score-matched cohort study 28
Environmental sustainability — an essential component of rational use of medicines 28
Cluster B personality disorders and psychotropic medications: a focused analysis of trends and patterns across sex and age groups 28
Call to action: Pharmaceutical residues in the environment: threats to ecosystems and human health 27
Medication use in Italian nursing homes: preliminary results from the national monitoring system 27
Adopting STOPP/START Criteria Version 3 in Clinical Practice: A Q&A Guide for Healthcare Professionals 27
Comorbid Depression and All-Cause Mortality in Type 2 Diabetes: A 9-Year Cohort Study 27
Factors Associated with Antidiabetic Medication Non-Adherence in Patients with Incident Comorbid Depression 27
Psychotropic medication use pre and post-diagnosis of cluster B personality disorder: a Quebec’s health services register cohort 27
Factors associated with potentially inappropriate opioid use in community-living older adults consulting in primary care 27
Factors associated with antidiabetic medication non-adherence in patients with incident comorbid depression 27
Association between stimulant and non-stimulant ADHD medications and completed suicide in adolescents and adults: A population-based nested case-control study 27
Scholarly publishing depends on peer reviewers 25
Risk of Mortality Associated with Potentially Inappropriate Medication Use Including Opioids in Older Adults 25
Leveraging digital medication adherence technologies to enhance sustainability of European health systems: ENABLE's key recommendations 25
Attitudes, barriers, and facilitators toward tools supporting appropriate prescribing among healthcare professionals: a cross-sectional study 24
The impact of incident depression on medication adherence in patients with type 2 diabetes 24
Post-marketing safety profile of cannabis products: Signals from the FDA adverse event reporting system 24
Trends of polypharmacy among older adults with schizophrenia in Quebec, Canada between 2000 and 2017 23
The Association between Depression and Medication Nonpersistence in New Users of Antidiabetic Drugs 23
Sialylexoenitols as precursors for new analogues of sialidase inhibitors 23
The environmental impact of pharmaceuticals in Italy: Integrating healthcare and eco-toxicological data to assess and potentially mitigate their diffusion to water supplies 23
Trends in medication use during the COVID-19 pandemic in Quebec, Canada 23
ADHD Medication Use and Psychiatric Comorbidity, Trauma and Mortality in Children and Young Adults: A Cohort Study from Quebec, Canada 23
Risk of Psychotic Disorders Among Patients with Medical Cannabis Authorization: A Longitudinal Cohort Study 23
Global prevalence of antidepressant drug utilization in the community: protocol for a systematic review 23
Medication use in the year before and after a diagnosis of cluster B personality disorder: Trends and patterns between 2002 and 2018 in Quebec, Canada 22
Cluster B personality disorders and psychotropic medications: a focused analysis of trends and patterns across sex and age groups 22
Stable GM3 lactone mimetic raises antibodies specific for the antigens expressed on melanoma cells 22
Estimate of incidence and prevalence of type 1 diabetes using electronic drug prescription archives 22
Incidence of Depression and Associated Factors in Patients With Type 2 Diabetes in Quebec, Canada: A Population-Based Cohort Study 22
What Is the Safety Profile of Cannabis-Based Medications? Analysis of the Post-Marketing Signals from the FDA Adverse Event Reporting System 21
Incidence of depression and associated factors in patients with type 2 diabetes in Quebec, Canada 21
Prevalence and determinants of long-term utilization of antidepressant drugs: A retrospective cohort study 21
Incidence of Depression in Patients with Diabetes in Quebec: A Population-Based Cohort Study 21
Agreement Between Medico-Administrative Database Algorithms and Survey-Based Diagnoses for Depression and Anxiety in Older Adults 21
What methods are used to study the association between medication adherence trajectories, estimated with the group-based trajectory modeling (GBTM) method, and health-related outcomes?—a protocol for a systematic review 21
Health care system costs related to potentially inappropriate medication use involving opioids in older adults in Canada 20
Structural study of liposomes loaded with a GM3 lactone analogue for the targeting of tumor epitopes 20
Use of Quebec medico-administrative databases for mental health studies: Opportunities, methodological challenges and limitations – The case of depression among diabetic subjects 19
Strategies and Tools for Supporting the Appropriateness of Drug Use in Older People 19
Stereoselective synthesis of 1,3-disaccharides through diels-alder reactions: Part 2[ ]: Convenient protecting groups for heterodienes and conformational evaluations 19
The prevalence of chronic antidepressant drugs prescriptions in the province of Bologna, Italy 19
Psychiatric and non-psychiatric polypharmacy among older adults with schizophrenia: Trends from a population-based study between 2000 and 2016 18
Patient and health system factors associated with potentially inappropriate opioid use in non-cancer community-dwelling older adults 18
Learning of clinical pharmacology by future prescribers in Bologna: Teachers' and students' reflections on the way forward 18
Utilization of Health Care Services by Patients With Cluster B Personality Disorders or Schizophrenia 18
Environmentally sustainable prescribing: recommendations for EU pharmaceutical legislation 17
Assessing the environmental impact of medicines in Italy using data from the Italian Medicines Agency 16
Synthetic Immunogenic Glycoconjugate for melanoma immunotherapy 15
Prevalence of Depression in Patients with Type 2 Diabetes (T2D) in Quebec 14
Call to action: Pharmaceutical residues in the environment: threats to ecosystems and human health 13
null 11
Introduction of Biopharmaceuticals in Europe: A Cross-Sectional Study of Early Diffusion Patterns and Data Availability 5
Polypharmacy Definitions for Multimorbid Older Adults Need Stronger Foundations to Guide Research, Clinical Practice and Public Health 3
Totale 2.215
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.460
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.460
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/2025730 0 0 0 0 0 0 0 0 199 363 132 36
2025/20261.485 158 160 418 531 214 4 0 0 0 0 0 0
Totale 2.215